Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Could the Silver Price Really Hit US$100 per Ounce? (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Top 10 Copper-producing Companies (Updated 2024)

Top 10 Countries for Natural Gas Production (Updated 2024)

7 Biggest Lithium-mining Companies

11 Canadian Cryptocurrency ETFs (Updated 2024)

Where Does Tesla Get its Lithium? (Updated 2024)

Top 7 Canadian Lithium Stocks of 2024

Top 5 Canadian Uranium Stocks of 2024

Trending Press Releases

Galan Lithium Limited (ASX: GLN) – Trading Halt

Edison Lithium Expands Portfolio with Acquisition of Additional Sodium Brine Claim in Saskatchewan

Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study

Bitcoin Well Launches Cash Vouchers For Canadian Customers

Osisko Metals Reports Preliminary Metallurgical Testwork Results From Gaspé Copper

Steppe Gold Enters Into Share Exchange Agreement to Acquire Boroo Gold and Agrees to Sell the Tres Cruces Oxide Project

More Press Releases
Trending Companies

Ramp Metals

RAMP:CC

Purpose Bitcoin ETF

BTCC:CA

Galan Lithium

GLN:AU

Carbon Done Right

KLX:CC
More Companies
Trending Reports

2024 EV Market Outlook Report

2024 Lithium Market Outlook

2024 Uranium Outlook (Updated for Q2)

Lithium Outlook for Australia

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold
Copper
Uranium
Oil and Gas
Artificial Intelligence
Biotech
loader

Acumen Pharmaceuticals Inc.

NASDAQ:ABOS:US
Press Releases

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer's disease. The company's lead drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets amyloid-beta oligomers.

×